New Medical Technology Development and Diffusion
Policy Challenges and Considerations
Download eBook for Free
|PDF file||1.6 MB||
Use Adobe Acrobat Reader version 10 or higher for the best experience.
Over the past decade, the rapid pace of medical technology development has created a large array of drugs, medical devices and healthcare services, many of which have greatly expanded the scope of treatable diseases. The diffusion of these technologies in the U.S. has helped countless individuals realize substantial improvements in life expectancy and overall quality of life. However, the development and diffusion of new medical technology have also presented several challenges for U.S. policy makers. The three papers that comprise this dissertation examine three policy issues that center on some of these challenges. The first paper examines how markets can fail to incentivize the development of new medical technology that address a public need and explore the lessons learned from the implementation of four different policy solutions. The second paper examines the role of the National Institutes of Health in new medical technology development and the extent to which its research grant program has encouraged the formation of biopharmaceutical commercial alliances. The last paper examines the Centers for Medicare and Medicaid Service's Accountable Care Organization program and whether its participants are changing the way that new medical technologies are used and adopted.
Research conducted by
This document was submitted as a dissertation in March 2014 in partial fulfillment of the requirements of the doctoral degree in public policy analysis at the Pardee RAND Graduate School. The faculty committee that supervised and approved the dissertation consisted of Krishna Kumar (Chair), David Auerbach, and Susan Gates.
This publication is part of the RAND Corporation Dissertation series. Pardee RAND dissertations are produced by graduate fellows of the Pardee RAND Graduate School, the world's leading producer of Ph.D.'s in policy analysis. The dissertations are supervised, reviewed, and approved by a Pardee RAND faculty committee overseeing each dissertation.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.